Drug name - Emend
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8258132 | MSD MERCK CO | Pharmaceutical composition of a tachykinin receptor antagonist |
Sep, 2027
(4 years from now) | |
Drugs and Companies using APREPITANT ingredient
Treatment: Prevention of nausea and vomiting associated with chemotherapy (cinv)
Dosage: FOR SUSPENSION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 125MG/KIT | FOR SUSPENSION;ORAL | Prescription |
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8258132 | MERCK | Pharmaceutical composition of a tachykinin receptor antagonist |
Sep, 2027
(4 years from now) | |
Drugs and Companies using APREPITANT ingredient
Treatment: Prevention of postoperative nausea and vomiting; for the prevention of nausea and vomiting associated with chemotherapy
Dosage: CAPSULE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 40MG | CAPSULE;ORAL | Discontinued |
| 80MG | CAPSULE;ORAL | Prescription |
| 125MG | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.